IPC signs MoUs with PMBI, NIPER Hajipur to boost drug quality, pharmacovigilance and research collaboration
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities
Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
The aim is to support Pharmacovigilance programme across the countries in the region
Subscribe To Our Newsletter & Stay Updated